McKessonMCK

NYSE · USA · Segment 8 of 8 in the Medicine, pharma & life science value chain: Distribution & pharmacy infrastructure

Medicines reach the counter through wholesalers, and McKesson is one of them: its customers run from pharmacies to hospitals and clinics across the US. Alongside distribution it sells services to pharmacy operators and runs an oncology network.

Distribution & pharmacy infrastructure: Wholesalers, distribution and pharmacy chains that get medicines to patients.

Key metrics

Market cap

$101B

Price

$873.79

Today

+1.7%

Return YTD

+4.7%

Return 1Y

+21.7%

P/E

21.9

P/S

0.2

P/B

17.1

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

DistributionWholesalerOncology servicesPharmacy infrastructure

In the value chain

Products & services

Drug distribution
Pharmacy services
Oncology network

Competitors

Risks

Low-margin business
Opioid-related settlements

Supply chain

Supplies →

CVS HealthCVS

← Suppliers

Johnson & JohnsonJNJ Bristol Myers SquibbBMY AbbVieABBV Vertex PharmaceuticalsVRTX Gilead SciencesGILD BiogenBIIB Neurocrine BiosciencesNBIX Eli LillyLLY PfizerPFE Merck & Co.MRK

Full supply chain for MCK →

Same segment: Distribution & pharmacy infrastructure

UnitedHealthUNH CVS HealthCVS The Cigna GroupCI CencoraCOR Cardinal HealthCAH

Compare MCK

MCK vs UNH MCK vs CVS MCK vs CI MCK vs COR MCK vs CAH

See where McKesson sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →